Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-24-026020
Filing Date
2024-07-02
Accepted
2024-07-02 16:26:35
Documents
21

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 3399677
2 ex4-1.htm EX-4.1 1040
3 ex23-1.htm EX-23.1 4172
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 12399
5 logo_002.jpg GRAPHIC 5233
6 formf-1a_021.jpg GRAPHIC 34196
7 formf-1a_022.jpg GRAPHIC 34196
8 formdrs_002.jpg GRAPHIC 24676
9 formdrs_007.jpg GRAPHIC 1606
10 formdrs_008.jpg GRAPHIC 1603
11 formdrs_009.jpg GRAPHIC 1483
12 formdrs_010.jpg GRAPHIC 1454
13 formdrs_011.jpg GRAPHIC 1598
14 formdrs_012.jpg GRAPHIC 1474
15 formdrs_013.jpg GRAPHIC 1472
16 formdrs_014.jpg GRAPHIC 1303
17 formdrs_015.jpg GRAPHIC 1474
18 formdrs_016.jpg GRAPHIC 1474
19 formdrs_017.jpg GRAPHIC 29753
20 formdrs_020.jpg GRAPHIC 16564
21 ex4-1_001.jpg GRAPHIC 292582
  Complete submission text file 0001493152-24-026020.txt   4043130
Mailing Address BLOCK 1090 LOWER DELTA ROAD, #06-08 SINGAPORE U0 169201
Business Address BLOCK 1090 LOWER DELTA ROAD, #06-08 SINGAPORE U0 169201 (65) 8512 7275
Cuprina Holdings (Cayman) LTD (Filer) CIK: 0001995704 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-277731 | Film No.: 241095869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)